Aldose Reductase and Complications of Diabetes
- DAVID G. COGAN, M.D.;
- JIN H. KINOSHITA, Ph.D.;
- PETER F. KADOR, Ph.D.;
- W. GERALD ROBISON, Ph.D.;
- MANUEL B. DATILIS, M.D.;
- L. MICHAEL COBO, M.D.; and
- CARL KUPFER, M.D.
Abstract
Tissues of the eye affected by diabetes are the lens, cornea, and retina. The lens becomes cataractous through osmotic swelling of its cortical fibers. Sorbitol, formed in the presence of aldose reductase, accumulates in the lens during hyperglycemia. Dulcitol similarly accumulates in the presence of galactosemia. Cataractogenesis in both cases can be prevented by inhibitors of aldose reductase. The efficacy of synthetic inhibitors differs in various tissues and species, but they react with aldose reductase at a common structural site. The most promising inhibitor is sorbinil. Diabetic retinopathy is similarly related to sorbitol accumulation and may be prevented or reversed by inhibition of aldose reductase. Healing of corneal wounds in diabetes is facilitated by enzyme inhibition. Retinal vasculopathy of diabetes is due to selective loss of the intramural pericytes that normally form structural elements in the retinal capillary walls. The vulnerability of these cells is due to their aldose reductase content. Whether inhibition of aldose reductase will prevent retinopathy is being tested in a randomized trial conducted by the National Eye Institute.
Article and Author Information
-
▸An edited transcription of a Clinical Staff Conference held on 26 May 1983 at the Clinical Center, Bethesda, Maryland, sponsored by the National Eye Institute, National Institutes of Health, U.S. Department of Health and Human Services.
-
▸Authors who wish to cite a section of this conference and specifically indicate its author can use this example for the form of reference:
KINOSHITA JH. Concept of aldose reductase and diabetic cataracts, pp. 82-4. In: COGAN DG, moderator. Aldose reductase and complications of diabetes. Ann Intern Med. 1984;101:82-91.
-
▸Requests for reprints should be addressed to David G. Cogan, M.D.; Building 10, Room 10C205, National Institutes of Health; Bethesda, MD 20205.
RSS Feeds









